Angiotensin receptors: a new role in cancer?

被引:370
作者
Deshayes, F [1 ]
Nahmias, C [1 ]
机构
[1] Inst Cochin, CNRS,UMR 8104, INSERM,U567, Dept Biol Cellulaire, F-75014 Paris, France
关键词
D O I
10.1016/j.tem.2005.07.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There is increasing evidence that Angiotensin II (AngII), a major regulator of blood pressure and cardiovascular homeostasis, is involved in the regulation of cell proliferation, angiogenesis, inflammation and tissue remodeling, which suggests that this peptide might also play a role in cancer. This review focuses on the expression and function of Angiotensin I-converting enzyme (ACE) and AngII receptors in various aspects of cancer. Recent experimental data suggests that ACE inhibitors and AngII type 1 receptor (AT1R) antagonists have beneficial effects on tumor progression, vascularization and metastasis, and that the AngII type 2 receptor (AT2R) subtype has a potential role in cancer. An overview of the major intracellular signaling pathways associated with AT1R and AT2R activation in cancer cells, as well as in endothelial and inflammatory cells, is presented here.
引用
收藏
页码:293 / 299
页数:7
相关论文
共 69 条
[1]   Direct evidence of leukocyte adhesion in arterioles by angiotensin II [J].
Alvarez, A ;
Cerda-Nicolás, M ;
Nabah, YNA ;
Mata, M ;
Issekutz, AC ;
Panés, J ;
Lobb, RR ;
Sanz, MJ .
BLOOD, 2004, 104 (02) :402-408
[2]   Blockage of angiotensin II type I receptor decreases the synthesis of growth factors and induces apoptosis in C6 cultured cells and C6 rat glioma [J].
Arrieta, O ;
Guevara, P ;
Escobar, E ;
García-Navarrete, R ;
Pineda, B ;
Sotelo, J .
BRITISH JOURNAL OF CANCER, 2005, 92 (07) :1247-1252
[3]   Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells [J].
Benndorf, R ;
Böger, RH ;
Ergün, S ;
Steenpass, A ;
Wieland, T .
CIRCULATION RESEARCH, 2003, 93 (05) :438-447
[4]   Vascular inflammation and the renin-angiotensin system [J].
Brasier, AR ;
Recinos, A ;
Eledrisi, MS .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (08) :1257-1266
[5]   Anti-tumor activity of a combination of plasminogen activator and captopril in a human melanoma xenograft model [J].
De Groot-Besseling, RRJ ;
Ruers, TJM ;
Van Kraats, AA ;
Poelen, GJM ;
Rutter, DJ ;
De Waal, RMW ;
Westphal, JR .
INTERNATIONAL JOURNAL OF CANCER, 2004, 112 (02) :329-334
[6]   Increased angiotensin II type-2 receptor density in hyperplasia, DCIS and invasive carcinoma of the breast is paralleled with increased iNOS expression [J].
De Paepe, B ;
Verstraeten, VLRM ;
De Potter, CR ;
Bullock, GR .
HISTOCHEMISTRY AND CELL BIOLOGY, 2002, 117 (01) :13-19
[7]   Growth stimulatory angiotensin II type-1 receptor is upregulated in breast hyperplasia and in situ carcinoma but not in invasive carcinoma [J].
De Paepe, B ;
Verstraeten, VLRM ;
De Potter, CR ;
Vakaet, LAML ;
Bullock, GR .
HISTOCHEMISTRY AND CELL BIOLOGY, 2001, 116 (03) :247-254
[8]   Evidence for activation of the renin-angiotensin system in the human prostate:: increased angiotensin II and reduced AT1 receptor expression in prostatic hyperplasia [J].
Dinh, DT ;
Frauman, AG ;
Somers, GR ;
Ohishi, M ;
Zhou, JL ;
Casley, DJ ;
Johnston, CI ;
Fabiani, ME .
JOURNAL OF PATHOLOGY, 2002, 196 (02) :213-219
[9]   Identification, distribution, and expression of angiotensin II receptors in the normal human prostate and benign prostatic hyperplasia [J].
Dinh, DT ;
Frauman, AG ;
Sourial, M ;
Casley, DJ ;
Johnston, CI ;
Fabiani, ME .
ENDOCRINOLOGY, 2001, 142 (03) :1349-1356
[10]   Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth [J].
Egami, K ;
Murohara, T ;
Shimada, T ;
Sasaki, K ;
Shintani, S ;
Sugaya, T ;
Ishii, M ;
Akagi, T ;
Ikeda, H ;
Matsuishi, T ;
Imaizumi, T .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (01) :67-75